Pasar al contenido principal

USO DE AGREGADOS DE PROTEINAS COMO PLATAFORMAS DE ADAPTACION A ESTIMULOS NOCIVOS

PID2022-142382OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Alternative low-populated conformations prompt phase transitions in polyalanine repeat expansions

  • Antón, Rosa
  • Treviño, Miguel A.
  • Pantoja-Uceda, D.
  • Félix, Sara
  • Babu, María
  • Cabrita, Eurico J.
  • Zweckstetter, Markus
  • Tinnefeld, Philip
  • Vera, Andrés M.
  • Oroz, Javier
14 pags., 6 figs., 1 tab., Abnormal trinucleotide repeat expansions alter protein conformation causing malfunction and contribute to a significant number of incurable human diseases. Scarce structural insights available on disease-related homorepeat expansions hinder the design of effective therapeutics. Here, we present the dynamic structure of human PHOX2B C-terminal fragment, which contains the longest polyalanine segment known in mammals. The major α-helical conformation of the polyalanine tract is solely extended by polyalanine expansions in PHOX2B, which are responsible for most congenital central hypoventilation syndrome cases. However, polyalanine expansions in PHOX2B additionally promote nascent homorepeat conformations that trigger length-dependent phase transitions into solid condensates that capture wild-type PHOX2B. Remarkably, HSP70 and HSP90 chaperones specifically seize PHOX2B alternative conformations preventing phase transitions. The precise observation of emerging polymorphs in expanded PHOX2B postulates unbalanced phase transitions as distinct pathophysiological mechanisms in homorepeat expansion diseases, paving the way towards the search of therapeutics modulating biomolecular condensates in central hypoventilation syndrome., This work was supported by the grants PID2019-109276RA-I00 and PID2022-142382OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by FEDER A way to make Europe (to J.O.), and by donations from the Spanish and Mexican Ondine Associations. J.O. was a recipient of a Leonardo Grant from the Spanish BBVA Foundation (BBM_TRA_0203) and is a Ramón y Cajal Fellow of the Spanish AEI-Ministry of Science and Innovation (RYC2018-026042-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”). E.C. acknowledges the funding by Fundação para a Ciência e a Tecnologia (FCT-Portugal) of the UCIBIO project (UIDP/04378/2020 and UIDB/04378/2020) and Associate Laboratory Institute for Health and Bioeconomy – i4HB Project (LA/P/0140/2020). S.F. is a PhD student under the PTNMRPhD Program from FCT-Portugal (PD/BD/148028/2019). M.Z. was supported by the European Research Council (ERC) under the EU Horizon 2020 research and innovation programme (grant agreement No. 787679). P.T. acknowledges funding from the Free State of Bavaria through the ONE MUNICH Project Munich Multiscale Biofabrication and A.M.V. is grateful for the support from the Center for NanoScience Munich. N.M.R. experiments were performed in the “Manuel Rico” NMR Laboratory (LMR) of the Spanish National Research Council (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB).IC)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Linear epitopes of bony fish β-parvalbumins

  • Franciskovic, Eric
  • Thörnqvist, Linnea
  • Greiff, Lennart
  • Gasset, M.
  • Ohlin, Mats
12 pags., 10 figs., 2 tabs., Fish β-parvalbumins are common targets of allergy-causing immunity. The nature of antibody responses to such allergens determines the biological outcome following exposure to fish. Specific epitopes on these allergens recognised by antibodies are incompletely characterised., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by Spanish MCIN/AEI PID2019-103845RB-C21 and PID2022-142382OB-I00 projects (MG), and by the Swedish Research Council (grant 2019-01042) (MO)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

J-domain proteins as modulators of amyloid protein aggregation involved in amyotrophic lateral sclerosis

  • Nuland, Nicolás Enrique van
  • Álvarez, Eva
  • Mukhi, Mayur
  • Núñez-Ramírez, Rafael
  • Fernández-Tornero, Carlos
  • Hervás, Rubén
  • Gasset, María
  • Oroz, Javier
Investigating the molecular mechanisms and the proteins implicated in the regulation of aggregation, protein misfolding, and the stabilization of native conformations is pertinent for prospective biological advancements. Efforts have been focused on understanding the implications of HSP70 and HSP90 chaperones in TDP-43 pathophysiology as their interplay is key in correct protein regulation in several diseases such as ALS. However, although they have recently emerged as leaders in protein chaperoning, the implications of the HSP40 family of co-chaperones in TDP-43 interactome and proteostasis in degenerating motoneurons are not well understood. Recently, we described that HSP40 or J-domain protein (JDPs) subfamilies present a distinct modulation of TDP-43 aggregation mechanism, as they either suppress or enhance the aggregation of the prion like domain (PLD), encouraging a further study to better understand this differentiation and its relevance in TDP-43 pathogenesis. This work focuses on JDP family members of subclass ¿A¿ (DNAJA2), ¿B¿ (DNAJB1) and ¿C¿ (DNAJC7) as they have been reported, together with DNAJB6, as major chaperones in TDP-43 proteostasis. We seek to provide fundamental understanding on co-chaperones mode of action and their interplay in the key molecular processes triggering pathogenesis. The deep structural characterization and dynamic study of the molecular complex formed by JDPs and TDP-43 we aim to obtain is key for the future exogenous modulation of TDP-43 aggregation mechanism and the development of new therapeutic strategies towards neurodegenerative diseases.We seek to describe human DNAJA2, DNAJB1 and DNAJC7 conformational ensembles by high-field, solution NMR spectroscopy to understand TDP-43 differential recognition. NMR spectroscopy is the only high-resolution structural technique that can characterize the disordered regions flanking the J domains, which we hypothesize are crucial in TDP-43 triaging. Moreover, we aim to determine the impact of the co-chaperones in TDP-43 aggregation, to uncouple aggregate structure and toxicity. To do so, we use kinetic binding assays to address the differential modulation of the co-chaperones, fluorescence experiments to follow TDP-43¿s liquid-to-solid transition and transmission electron microscopy to determine the morphology and polymorphism of TDP-43 amyloids We have fully assigned constructs for the three chaperones, which recapitulate the dynamic nature of the full sequences. The chaperones appear soluble and monomeric and enabled a detailed structural and dynamic study. The mechanism of recognition of TDP-43's PLD by the three chaperones differs, driven by their J-domains and adjacent disordered regions, which collectively govern both binding specificity and phase separation. In agreement with previous results from the group, we show here that the assembly of PLD amyloid fibrils is significantly enhanced in the presence of DNAJB1 and delayed in the presence of DNAJA2 and DNAJC7. High-quality TEM analysis enabled us to monitor that DNAJA2 and DNAJC7 trap TDP¿43¿s PLD into oligomeric structures, while DNAJB1 promotes PLD fibrils with significantly different morphology.This study provides crucial insights into the distinct roles of J-domain proteins (JDPs) DNAJA2, DNAJB1, and DNAJC7 in modulating TDP-43 aggregation, a key pathological hallmark in neurodegenerative diseases such as ALS. Through a combination of high-field NMR spectroscopy, kinetic binding assays, fluorescence, and transmission electron microscopy, we have uncovered that these co-chaperones exert divergent effects on the phase separation and fibrillization of TDP-43¿s prion-like domain (PLD). Notably, DNAJB1 enhances PLD aggregation and short fibril formation, while DNAJA2 and DNAJC7 suppress fibrillization by stabilizing oligomeric intermediates. These findings support a […], Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice

  • Muela-Zarzuela, Inés
  • Alcocer-Gómez, Elisabet
  • Suarez-Rivero, Juan M.
  • Low, Evon
  • Ishaq, Abbas
  • Azkargorta, Mikel
  • Luque-Sierra, Amparo
  • Martin, Franz
  • Elortza, Félix
  • Astorga-Gamaza, Antonio
  • Antón, Rosa
  • Bali, Sofía
  • Tamargo-Azpilicueta, Joaquin
  • Guerra-Castellano, Alejandra
  • Díaz-Moreno, Irene
  • Joachimiak, Lukasz A.
  • Oroz, Javier
  • Ruiz-Cabello, Jesús
  • von Zglinicki, Thomas
  • Sanz, Alberto
  • Cordero, Mario D.
The NLRP3 inflammasome has been implicated in a wide range of human diseases, including cardiovascular, metabolic, neurodegenerative (such as Alzheimer's disease), and other age-related conditions. This has positioned NLRP3 as a promising pharmacological target. Numerous studies have shown that complete NLRP3 ablation can prevent or mitigate these diseases. However, total elimination of NLRP3 is not a feasible therapeutic strategy for the millions of patients affected by these degenerative disorders. Consequently, drug development efforts have focused on partial inhibition of NLRP3 using compounds that reduce its expression or activity. Paradoxically, although many studies have used Nlrp3 knockout mouse models, Nlrp3 haploinsufficient mice-more representative of the effects of pharmacological inhibition-are rarely included and remain poorly characterized. Here, we report the long-term effects of Nlrp3 haploinsufficiency during aging. Although no overt differences were observed in early life, by 16 months of age, Nlrp3 heterozygous mice exhibited signs of accelerated inflammatory aging, driven by compensatory overexpression of NLRP1. Mechanistic studies provide evidence of a previously unidentified interaction between NLRP1 and NLRP3, forming a hybrid inflammasome that drives NLRP1-mediated inflammatory overactivation when NLRP3 expression is reduced. Accordingly, anti-inflammatory treatment provided notable but moderate improvement of the inflammatory phenotype, whereas genetic inhibition of Nlrp1 more consistently reduced inflammation and extended health span. Our findings reveal a previously unidentified compensatory interaction between NLRP1 and NLRP3 and suggest that multiinflammasome inhibition may offer a more effective strategy for treating aging and age-related diseases., This study was supported by grant PI21/01656 from the Instituto de Salud Carlos III (Spain), grant EMC21_00033 from the EMERGIA programme of the Junta de Andalucía, and grant CNS2024-154939 from the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación. Funding for open access publication was provided by the Universidad Pablo de Olavide/CBUA. J.R.-C . is funded by grant PID2021-123238OB- I00 and PID2024-155807OB- C 21 funded by the MCIN/AEI and from the Fundación contra la Hipertensión Pulmonar (Project Empathy). I.D.-M. is funded by grant PID2024-157414NB- I00 funded by the MICIU/AEI/10.13039/501100011033 and by ERDF/EU, Ramon Areces Foundation (LEUCYTO-FRA2025- MAR), grant FPU22/01094 funded by MICIU/AEI/10.13039/501100011033 and by ESF+ to J.T.-A., and grant PTQ2024-013941 funded by MICIU/AEI/10.13039/501100011033 to A.G.-C . J.O. is supported by the grants PID2019-109276RA- I00 and PID2022-142382OB- I00 funded by MCIN/AEI/10.13039/501100011033 and by FEDER A way to make Europe and by donations from the Spanish and Mexican Ondine Associations. J.O. was a recipient of a Leonardo Grant from the Spanish BBVA Foundation (BBM_TRA_0203) and a Ramón y Cajal Fellow of the Spanish AEI-Ministry of Science and Innovation (RYC2018-026042- I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”)., Peer reviewed